4
Changes in Ownership
Allogene Therapeutics, Inc. Filed Acc 0001209191-19-038866
Director acquired 16,377 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Kazam Joshua A · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-06-06 | Grant or award : show line 1 in the form | +16,377 | 1,407,028 | D |
Loading xslF345X03/doc4.xml…